Medicina basada en la evidencia: Un reto para el siglo XXI

Medicina Clinica

Volumn 111, Issue 14, 1998, Pages 552-557

  Brotons Cuixart, Carlos ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; EVIDENCE BASED MEDICINE;

EVIDENCE-BASED MEDICINE;

EID: 0032585109     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Campbell W, Scanlon DM. Bridging the Gap between research and practice. The role of continuing medical education. JAMA 1997; 277: 155-156.
2. Evidence-Based Medicine Working Group. JAMA 1992; 268: 2.420-2.425.
3. Haynes RB, Hayward RS, Lomas J. J Am Med Inform Assoc 1995; 2: 342-350.
4. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine. How to Practice and teach EBM. Nueva York: Churchill Livingstone, 1997.
5. Guerra Romero L. La medicina basada en la evidencia: un intento de acercar la ciencia al arte de la práctica clinica. Med Clin (Barc) 1996; 107: 377-382.
6. Goodle F. Medicine speeds up. En: Fishburn D, editor The world in 1997. Londres: The Economist Newspaper Ltd., 1996: 129-130.
7. Dary Taubes. Looking for the evidence in medicine. Science 1996; 272: 22-24.
8. Evidence-based Medicine: a powerful educational tool for clekship education. Am J Med 1997; 102: 427-432.
9. Bonfill Cosp X. La Colabaración Cochrane. Aten Primaria 1996; 18: 273-278.
10. Mandel JS, Bond JH, Church TR, Snover DC, Bradley M, Schuman LM et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1.365-1.371.
11. Kronborg O, Fenger C, Olesen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 1996; 348: 1.467-1.471.
12. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1.472-1.477.
13. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet 1993; 342: 395-398.
14. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345: 840-842.
15. The Canadian Task Force on the Periodic Health Examination. The Canadian Guide to clinical preventive health care. Ottawa: Ministry of Supply and Services, 1994.
16. Maynard A. Evidence based medicine: an incomplete method for informing treatment choices Lancet 1997; 349: 126-128.
17. Ellis J, Mulligan I, Rowe J, Sackett DL, on behalf of the A-Team, Nuffield Department of Clinical Medicine. Inpatient general medicine is evidence based. Lancet 1995; 346: 407-410.
18. Geddes JR, Game D, Jenkins NE, Peterson LA, Porriger GR, Sackett DL. In-patient psychiatric treatment is evidence-based. Proceedings of the Royal College of Psychiatrics Winter Meeting. Stratford, UK. 23-25 January, 1996.
19. Soriano N, Brotons C, Moral I, Casanova A, Vidai G, Permanyer G. Impacto de las publicaciones biomédicas en la incorporación de nuevas actitudes terapéuticas en la insuficiencia cardíaca y en el infarto de miocardio. Rev Esp Cardiol. En prensa.
20. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricu ar ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
21. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669-677.
22. Brotons C, Moral I, Antón JJ, Cobos M, Cucurull E, Gállego C et al. Tratamiento preventivo de la fibrilación auricular no reumática: de la eficacia de los ensayos clínicos a la efectividad en la práctica clínica. Aten Primaria 1997; 20: 367-371.
23. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low dosis of warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1.505-1.511.
24. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B, Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromobolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989; 1: 175-179.
25. Stroke Prevention in Atrial Fibrillation Study Group. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991; 84: 527-539.
26. Corinolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18: 349-355.
27. Ezekowitz MD, Bridgers SL, Kenneth JE, Carliner NH, Colling CL, Gornick CC et al. Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992; 327: 1.406-1.412.
28. Brotons C, Permanyer-Miralda G, Calvo F, Cascant P, Ribera A, Moral I, et al. Is prophylactic treatment after myocardial infarction evidence based? Eur Heart J. En prensa.
29. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1.383-1.389.
30. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1.001-1.009.
31. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
32. The Acute Infarction Ramipril (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-828.
33. Lidón RM, Mercé J, Gallart E, Miró E, Escudé T, Romero A et al. Infarto agudo de miocardio: diferencias de tratamiento en la mujer anciana. Rev Esp Geriatr. En prensa.
34. Gottlieb S, Goldbourt U, Boyko V, Barbash G, Mandelzweig L, Reicher-Reiss H, for the SPRINT and Thrombolytic Survey Groups. Improved outcome of elderly patients (≥ 75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel. Circulation 1997; 95: 342-350.